Retrotransposons Promote Dnmt3a-Mutant Clonal Hematopoiesis Through Aging-Related Stromal Inflammation

Zhang, Q., Hu, W., Theriot, J., Lee, M., Rinaldi, S., Kim, Y. J., Cai, D., Dickerson, K., Trowbridge, J., Yan, N., et al.

10.64898/2026.02.23.707588 · was preprinted

Surfaced because: matches the platform's topic region.

relevance 0.36 openness 0.00 novelty 0.45

Abstract

Clonal hematopoiesis (CH) is an age-related phenomenon driven by the expansion of mutant hematopoietic stem cell (HSC) clones, most commonly harboring mutations in DNMT3A. While inflammation is known to promote CH, the upstream triggers of this inflammatory state remain unclear. We show that aging selectively upregulates retrotransposons in the non-hematopoietic cell compartment of the murine bone marrow, particularly in mesenchymal stromal cells. Using in vivo competitive transplant models, we demonstrate that retrotransposon-induced inflammation cell-extrinsically promotes Dnmt3a-mutant HSC expansion. This competitive advantage arises from mutant HSC resistance to inflammation-driven cell cycle perturbations. Mechanistically, we show that retrotransposon activation induces type I interferon signaling via viral mimicry, such that stromal knockdown of either Irf3 or Sting abrogates the competitive advantage of Dnmt3a-mutant HSCs. Our findings establish stromal-selective retrotransposon reactivation as a previously unrecognized, non-cell-autonomous source of inflammation that contributes to age-associated CH. Key PointsO_LIRetrotransposons remodel the aging niche through viral mimicry pathways to promote Dnmt3a-mutant clonal hematopoiesis. C_LIO_LIRetrotransposon-mediated inflammation impairs wild-type HSC fitness, while Dnmt3a-mutant HSCs resist inflammatory changes. C_LI

Lifecycle

biorxiv v2 2026-07-09 source ↗

Discussion

No qualifying discussion yet.